Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis

NCT00175045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophagitis
Reflux

Interventions

DRUG: Lansoprazole
DRUG: Lansoprazole

Sponsor

Takeda